CIK: 0001598762
Total reported value
$29.0M
Reporting period: 2018-09-30 · Number of holdings: 7
Pharmstandard International S.A. disclosed 7 holdings in its latest 13F filing for the period ending 2018-09-30, with total reported value of $29.0M and a quarterly turnover rate of 41.9%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "P"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim ALNAEUR
-0.6% -$2.1M
Add PTGX
0.0% $2.7M
Trim PRTOEUR
0.0% -$804.0K
Trim JNCEEUR
0.0% -$655.0K
Trim 040221103
0.0% -$69.0K
New buy 64050Y100
Showing top 6 holdings (of 7 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALNAEUR | Allena Pharmaceuticals INC | Stock-Other | 32.28% | -13.61% | -0.58% | |
| 2 | PTGX | Protagonist Therapeutics INC | Stock-Other | 26.59% | +6.36% | — | |
| 3 | ✓ | Neon Therapeutics Inc | Stock-Other | 17.31% | +17.31% | NEW | |
| 4 | JNCEEUR | Jounce Therapeutics INC | Stock-Other | 12.65% | -4.71% | — | |
| 5 | PRTOEUR | Proteon Therapeutics INC | Stock-Other | 10.79% | -5.01% | — | |
| 6 | ✓ | Argos Therapeutics INC | Stock-Other | 0.38% | -0.33% | — |
Not enough priced holdings yet to compute performance
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2018-09-30 | 7 | $29.0M | 42 | |
| 2018-06-30 | 6 | $24.9M | 46 | |
| 2018-03-31 | 6 | $39.8M | 100 | |
| 2017-12-31 | 6 | $97.3M | 100 | |
| 2017-09-30 | 5 | $34.3M | 39 | |
| 2017-06-30 | 5 | $28.8M | 26 | |
| 2017-03-31 | 5 | $37.5M | 100 | |
| 2016-12-31 | 4 | $116.1M | 0 |
Pharmstandard International S.A.'s most significant position changes for 2018-09-30: New buy: Neon Therapeutics Inc; Trim: Allena Pharmaceuticals INC (ALNAEUR) — shares -0.58%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PTGX | Protagonist Therapeutics INC | +6.4% | — | Unchanged |
| 2 | ✓ | Argos Therapeutics INC | -0.3% | — | Unchanged |
| 3 | JNCEEUR | Jounce Therapeutics INC | -4.7% | — | Unchanged |
| 4 | PRTOEUR | Proteon Therapeutics INC | -5% | — | Unchanged |
| 5 | ALNAEUR | Allena Pharmaceuticals INC | -13.6% | -0.58% | Trim |
| 6 | ✓ | Neon Therapeutics Inc | — | NEW | New buy |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2018-09-30 | 2018-11-15 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-03 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-15 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-08-17 | Amendment | View on EDGAR |
| 2017-03-31 | 2017-05-12 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001536071
Total reported value
$29.0M
11 stks
2015-12-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001199406
Total reported value
$29.1M
4 stks
2020-12-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001737348
Total reported value
$29.1M
2 stks
2025-09-30
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0000200406
Total reported value
$652.4M
16 stks
2026-03-31
1 of the top 5 holdings overlap, including Protagonist Therapeutics INC
CIK 0000924020
Total reported value
$978.2M
21 stks
2021-06-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Protagonist Therapeutics INC
CIK 0001442276
Total reported value
$13.9M
41 stks
2019-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Allena Pharmaceuticals INC